Vectorite Biomedical Equity 2024

Equity Details

Analyzing Vectorite Biomedical's Equity

Vectorite Biomedical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vectorite Biomedical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Vectorite Biomedical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Vectorite Biomedical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Vectorite Biomedical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Vectorite Biomedical stock

What is the equity of Vectorite Biomedical this year?

Vectorite Biomedical has equity of 430.44 M TWD this year.

What was the equity of Vectorite Biomedical compared to the previous year?

The equity of Vectorite Biomedical has increased/decreased by -2.37% decreased compared to the previous year.

What impact does a high equity have on investors of Vectorite Biomedical?

A high equity is advantageous for investors of Vectorite Biomedical as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Vectorite Biomedical?

A low equity can be a risk for investors of Vectorite Biomedical, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Vectorite Biomedical affect the company?

An increase in equity of Vectorite Biomedical can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Vectorite Biomedical affect the company?

A reduction in equity of Vectorite Biomedical can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Vectorite Biomedical?

Some factors that can affect the equity of Vectorite Biomedical include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Vectorite Biomedical so important for investors?

The equity of Vectorite Biomedical is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Vectorite Biomedical take to change the equity?

To change equity, Vectorite Biomedical can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Vectorite Biomedical pay?

Over the past 12 months, Vectorite Biomedical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Vectorite Biomedical is expected to pay a dividend of 0 TWD.

What is the dividend yield of Vectorite Biomedical?

The current dividend yield of Vectorite Biomedical is .

When does Vectorite Biomedical pay dividends?

Vectorite Biomedical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Vectorite Biomedical?

Vectorite Biomedical paid dividends every year for the past 0 years.

What is the dividend of Vectorite Biomedical?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vectorite Biomedical located?

Vectorite Biomedical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vectorite Biomedical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vectorite Biomedical from 9/29/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Vectorite Biomedical pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Vectorite Biomedical in the year 2023?

In the year 2023, Vectorite Biomedical distributed 0 TWD as dividends.

In which currency does Vectorite Biomedical pay out the dividend?

The dividends of Vectorite Biomedical are distributed in TWD.